Clinical Neurology and Neurosurgery
Volume 112, Issue 3 , Pages 183-187 , April 2010

Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)

  • Guenther Bohlen

      Affiliations

    • Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    • ,
  • Thekla Meyners

      Affiliations

    • Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    • ,
  • Susanne Kieckebusch

      Affiliations

    • Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Radka Lohynska

      Affiliations

    • Department of Radiation Oncology, University Hospital, Prague, Czech Republic
    • ,
  • Theo Veninga

      Affiliations

    • Department of Radiotherapy, Dr. Bernard Verbeeten Institute, Tilburg, The Netherlands
    • ,
  • Lukas J.A. Stalpers

      Affiliations

    • Department of Radiotherapy, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Steven E. Schild

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, USA
    • ,
  • Dirk Rades

      Affiliations

    • Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    • Corresponding Author InformationCorresponding author at: Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lubeck, Ratzeburger Allee 160, D-23538 Lubeck, Germany. Tel.: +49 451 500 6661; fax: +49 451 500 3324.

Received 3 May 2009 ,Revised 4 November 2009 ,Accepted 6 November 2009.

References 

  1. Samson DJ, Seidenfeld J, Simon GR, Turrisi AT, Bonnell C, Ziegler KM, et al. Evidence for management of small cell lung cancer. ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:314S–323S
  2. Arnold SM, Patchell RA. Diagnosis and management of brain metastases. Hematol Oncol Clin North Am. 2001;15:1085–1107
  3. Wen PY, Black PM, Loeffler JS. Metastatic brain cancer. In:  deVita V,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001;p. 2655–2670
  4. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid tumor patients: natural history and results of treatment. Cancer. 1981;48:384–394
  5. Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med. 1998;30:296–299
  6. Harwood AR, Simson WJ. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys. 1977;2:1091–1094
  7. Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol. 1996;8:308–315
  8. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980;6:1–9
  9. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981;7:1633–1638
  10. Chatani M, Matayoshi Y, Masaki N, Inoue T. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol. 1994;170:155–161
  11. Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol. 2008;184:30–35
  12. Rades D, Kieckebusch S, Lohynska R, Lohynska R, Veninga T, Stalpers LJ, et al. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys. 2007;69:1509–1513
  13. Lagerwaard FJ, Levendag PC, Nowak PJCM, Eijkenboom WMH, Hanssens PEJ, Schmitz PIM. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43:795–803
  14. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751
  15. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  16. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:13–47
  17. Bruner DW, Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys. 1995;31:1353–1355
  18. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789–796
  19. Joiner MC, Van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In:  Steel GG editors. Basic clinical radiobiology. New York: Oxford University Press; 1997;p. 106–112
  20. Glatstein E. Hypofractionation, long-term effects, and the alpha/beta ratio. Int J Radiat Oncol Biol Phys. 2008;72:11–18
  21. Mehta M, Fowler J. Accelerated hypofractionation. Int J Radiat Oncol Biol Phys. 2005;61:299–313
  22. Rades D, Lohynska R, Veninga T, Stalpers LJ, Schild SE. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer. 2007;110:2587–2592
  23. Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer. 2007;110:1077–1082
  24. Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, et al. Whole-brain radiotherapy with 20Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Strahlenther Onkol. 2007;183:631–636
  25. Videtic GM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GH, Lee SY, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys. 2007;67:240–243
  26. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–1672
  27. Parikh S, Heron DE. Fractionated radiosurgical management of intramedullary spinal cord metastasis: a case report and review of the literature. Clin Neurol Neurosurg. 2009;111:858–861
  28. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45:427–434
  29. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol. 1998;16:3563–3569
  30. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys. 1999;43:549–558
  31. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA. 2006;295:2483–2491
  32. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007;68:1388–1395
  33. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22:157–165
  34. Rades D, Kueter JD, Hornung D, Veninga T, Hanssens P, Schild SE, et al. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol. 2008;184:655–662

PII: S0303-8467(09)00301-1

doi: 10.1016/j.clineuro.2009.11.004

Clinical Neurology and Neurosurgery
Volume 112, Issue 3 , Pages 183-187 , April 2010

Article Tools

* Image Usage & Resolution